Picture of Merit Medical Systems logo

MMSI — Merit Medical Systems News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Merit Medical Acquires Dialysis Catheter Portfolio, BioSentry Biopsy Tract Sealant System From AngioDynamics

June 8 (Reuters) - Merit Medical Systems Inc  MMSI.O :
    * MERIT MEDICAL ANNOUNCES ACQUISITION OF DIALYSIS CATHETER
PORTFOLIO AND THE BIOSENTRY® BIOPSY TRACT SEALANT SYSTEM FROM
ANGIODYNAMICS, INC. AND ACQUISITION OF THE SURFACER® INSIDE-OUT®
ACCESS CATHETER SYSTEM FROM BLUEGRASS VASCULAR TECHNOLOGIES,
INC.
    * MERIT MEDICAL SYSTEMS INC: MERIT RE-AFFIRMS FULL-YEAR 2023
FINANCIAL GUIDANCE ON STAND-ALONE BASIS
    * MERIT MEDICAL SYSTEMS INC: UPDATES FULL-YEAR 2023
FINANCIAL
GUIDANCE TO INCLUDE PARTIAL-YEAR IMPACT FROM ACQUISITIONS
    * MERIT MEDICAL SYSTEMS : ACQUISITION OF PORTFOLIO OF
DIALYSIS
CATHETER PRODUCTS, BIOSENTRY BIOPSY TRACT SEALANT SYSTEM FOR
$100 MILLION
    * MERIT MEDICAL SYSTEMS INC: SEES 2023 NON-GAAP EARNINGS PER
SHARE
$2.81 - $2.92

Source text for Eikon:  ID:nGNX8z3K0t 
Further company coverage:  MMSI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Merit Medical Systems

See all news